BMS splashes out $173M to build 2nd radiopharmaceutical plant in Indiana

Bristol Myers Squibb, by way of its RayzeBio unit, has taken a big step in furthering its commitment to radiopharmaceuticals, earmarking $173 million to build a new manufacturing facility in Whites | Bristol Myers Squibb will spend $173 million to build a second radiopharmaceutical manufacturing facility in Indiana to couple with its current site in Indianapolis. The new plant will be in nearby Whitestown.